Trial Profile
An explorative analysis of the effect of a beta 3 adrenoreceptor agonist (Mirabegron) on urethral pressure variations during filling cystometry
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2014
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 18 Dec 2014 New trial record